StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research report released on Sunday morning. The firm issued a buy rating on the stock.
Mannatech Stock Down 1.1 %
MTEX stock opened at $14.73 on Friday. The firm has a market cap of $27.77 million, a PE ratio of -18.18 and a beta of 1.04. Mannatech has a 12 month low of $6.75 and a 12 month high of $15.25. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. The firm has a 50 day simple moving average of $9.92 and a 200 day simple moving average of $8.27.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The company had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- Market Cap Calculator: How to Calculate Market Cap
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Effectively Use the MarketBeat Ratings Screener
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Best Stocks Under $10.00
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
